IP Library Granted Patent US 11,571,470
Granted Patent B2
US 11,571,470 · App. 17/486,683 · Granted Feb 7, 2023

IL-15-based fusions to IL-12 and IL-18

Inventors: Warren D. Marcus (Miramar, FL); Robert Newman (Miramar, FL); Bai Liu (Cooper City, FL); Lijing You (Miramar, FL); Lin Kong (Miramar, FL); Peter Rhode (Miami, FL); Hing C. Wong (Weston, FL)
Assignee: Altor Bioscience LLC
A61K39/00114A61K47/6811A61P35/00C07K14/54C07K14/5434C07K14/5443C07K14/715C07K16/283C12N15/62C07K2319/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,571,470
App. No.
17/486,683
Granted
Feb 7, 2023
Kind
B2
Abstract

The invention features multi-specific fusion protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to IL-12 or IL-18.

Claims (6)

1. An isolated fusion protein complex comprising: a first soluble protein comprising an interleukin-15 (IL-15) polypeptide domain and an IL-18 polypeptide domain, and a second soluble protein comprising a soluble IL-15 receptor alpha sushi (IL-15RαSu) polypeptide domain and an IL-12 polypeptide domain,

wherein the IL-15 polypeptide domain binds to the IL-15RαSu polypeptide domain to form the soluble fusion protein complex.

2. The soluble fusion protein complex of claim 1 , wherein the IL-15 polypeptide is an IL-15 variant comprising an N72D mutation (IL-15N72D).

3. The soluble fusion protein complex of claim 1 , wherein the IL-12 polypeptide domain comprises the p40 and p35 subunits of IL-12.

4. The soluble fusion protein complex of claim 3 , wherein the p40 and p35 subunits are linked by a flexible polypeptide linker into a single-chain format.

5. A soluble fusion protein complex comprising two soluble fusion protein complexes of claim 1 covalently linked together.

Assignments (4)
SECURITY INTEREST Recorded Jan 2, 2024
From: IMMUNITYBIO, INC.; NANTCELL, INC.; RECEPTOME, INC.; VBC HOLDINGS LLC; ALTOR BIOSCIENCE, LLC; ETUBICS CORPORATION; IGDRASOL, INC.
To: INFINITY SA LLC, AS PURCHASER AGENT
Reel/Frame 066179/0074 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2021
From: MARCUS, WARREN D.; NEWMAN, ROBERT G.; LUI, BAI; YOU, LIJING; KONG, LIN; RHODE, PETER
To: ALTOR BIOSCIENCE CORPORATION
Reel/Frame 057991/0094 →
MERGER Recorded Nov 2, 2021
From: ALTOR BIOSCIENCE CORPORATION
To: ALTOR BIOSCIENCE LLC
Reel/Frame 057991/0418 →
CONSULTING AGREEMENT Recorded Nov 2, 2021
From: WONG, HING C.
To: ALTOR BIOSCIENCE LLC
Reel/Frame 057991/0713 →
Continuity (3)
Continuation 15913837 · Mar 6, 2018
Provisional Application 62467623 · Mar 6, 2017
Related Publication 20220062399A1 · Mar 3, 2022
Cited By (1)
US 12,233,116